Axitinib (Compound)

Synonyms:Axitinib, 319460-85-0, AG-013736, Inlyta, AG 013736, (E)-N-Methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide, UNII-C9LVQ0YUXG, AG-13736, AG013736, C9LVQ0YUXG, N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide, CHEBI:66910, (E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzamide, N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide, MFCD09837898, NSC757441, N-methyl-2-({3-[(E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide, NCGC00241108-01, S1005, DSSTox_CID_28975, DSSTox_RID_83240, DSSTox_GSID_49049, 319463-51-9, Axitinib (AG 013736), C22H18N4OS, N-methyl-2-({3-[(E)-2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide, CAS-319460-85-0, axitinibum, Axitinib [USAN:INN:JAN], 4agc, Inlyta (TN), AG13736, 4ag8, Axitinib (JAN/USAN), AG-013736;Axitinib, Axitinib,AG-013736, MLS006010164, SCHEMBL172918, GTPL5659, Axitinib, >=98% (HPLC), CHEMBL1289926, DTXSID3049049, SCHEMBL22930506, BDBM25117, CHEBI:94568, EX-A337, QCR-109, SYN1014, BCPP000372, AOB87786, BCP01371, ZINC3816287, Tox21_113597, NSC799341, AKOS015902898, Tox21_113597_1, AC-1539, BCP9000345, CCG-264772, CS-0116, DB06626, KS-1448, NSC 757441, NSC-757441, NSC-799341, Benzamide, N-methyl-2-((3-((E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)-, NCGC00241108-04, NCGC00241108-06, HY-10065, SMR002530046, AB0008632, AM20090673, SW219464-1, D03218, AB01274739-01, AB01274739_02, 460A850, SR-01000941566, J-502064, Q-200662, Q4830631, SR-01000941566-1, BRD-K29905972-001-01-4, BRD-K29905972-001-02-2, Benzamide, N-methyl-2-((3-((1E)-2-(2-pyridinyl)ethenyl)-1H-indazo)-6-yl)thio)-, Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-, N-Methyl-[[3[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-benzamide, N-methyl-2-({3-[(E)-2-pyridin-2-ylethenyl]-2H-indazol-6-yl}sulfanyl)benzamide, N-METHYL-2-(3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL)-BENZAMIDE

Pubchem:PUBCHEM:60182318

Id:6450551

Description:nan